Angina Pectoris: Clinical Trials

24 trials for Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 unknown. 24 Phase 3, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 324Unknown 24
Phase 25Unknown 5

Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
De-escalation to ticagrelor 60 mg at day 30, De-escalation to prasugrel 5 mg at day 30, Switch to ticagrelor 60 mg at day 45 - Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Phase 3UnknownCollegium Medicum w Bydgoszczy502023-04-012023-03-22
Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia
Ad5FGF-4, Placebo - Angina, Stable
Phase 3UnknownAngionetics Inc.1602023-01-012022-07-19
Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome
Ticagrelor 90mg, Ticagrelor 60mg, Aspirin - STEMI, NSTEMI
Phase 3UnknownCollegium Medicum w Bydgoszczy45002022-02-072023-04-21
Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms
Allopurinol 300 MG, Placebo oral tablet - Refractory Angina
Phase 2 / Phase 3UnknownMinistry of Health, Brazil402021-03-032021-02-24
Rhodiola Rosea for Coronary Microvascular Disease
Rhodiola Rosea Capsules, Placebo - Coronary Microvascular Disease
Phase 2 / Phase 3UnknownQilu Hospital of Shandong University1142020-01-012020-01-06
Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
Vitamin E, N-acetyl cysteine, Placebo oral capsule - Coronary Artery Disease, Coronary Artery Angiography
Phase 3UnknownRajaie Cardiovascular Medical and Research Center10002018-11-012018-11-30
Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and Diabetes
trimetazidine, Placebo Oral Tablet - Diabetes Mellitus, Angina, Unstable
Phase 3UnknownUniversity of Sao Paulo General Hospital1202018-10-012018-10-24
Effect of External Counter Pulsation on Coronary Artery Disease
External Counter Pulsation - Stable Chronic Angina, Coronary Artery Disease
Phase 3UnknownEighth Affiliated Hospital, Sun Yat-sen University3802018-06-082017-12-13
The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery
Ticagrelor, Placebo - Coronary Artery Disease, Stable Angina
Phase 3UnknownJ.M. ten Berg4872015-03-012020-04-27
BioFreedom US IDE Feasibility Trial
BioFreedom drug coated coronary stent - Ischemic Heart Disease, Stable Angina
Phase 2 / Phase 3UnknownBiosensors Europe SA722014-08-012015-04-01
Efficacy and Safety of Monocordil Manufactured by Laboratórios Baldacci
Isosorbide-5-mononitrate - Stable Angina
Phase 3UnknownLaboratórios Baldacci S.A862014-07-012014-06-02
Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)
Genotyping, Phenotyping - Stable Angina
Phase 3UnknownMedical University of Warsaw1502013-03-012018-12-24
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
Atorvastatin - Contrast Induced Nephropathy
Phase 3UnknownIsfahan University of Medical Sciences2012-01-012014-04-14
Impact of Different Treatment in Multivessel Non ST Elevation Myocardial Infarction (NSTEMI) Patients: One Stage Versus Multistaged Percutaneous Coronary Intervention (PCI)
One-Stage group, Multi-Staged group - Non ST Segment Elevation MI and Unstable Angina
Phase 3UnknownGennaro Sardella2472011-10-012011-11-24
Dual Antiplatelet Therapy Tailored on the Extent of Platelet Inhibition
comparison of different dosage of clopidogrel, doubled therapy - Unstable Angina, NSTEMI
Phase 3UnknownUniversity of Florence4422008-11-012008-10-24
Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)
Adenosin, placebo, Clopidogrel - Stable Angina, Percutaneous Coronary Intervention
Phase 3UnknownUniversity of Roma La Sapienza602008-09-012009-05-06
Treatment of Refractory Angina Pectoris by Shock Wave Therapy
Extra-corporeal shockwave, Anti-hypertensive drugs - Angina Pectoris
Phase 3UnknownUniversal Research Group602008-02-012008-10-21
Coronary Computed Tomographic Angiography in Emergency Department Chest Pain Patients at Intermediate Risk of Acute Coronary Syndrome
Coronary Computed Tomographic Angiography - Acute Coronary Syndrome, Acute Myocardial Infarction
Phase 3UnknownVancouver General Hospital1502007-11-012007-11-20
Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization
Ad5FGF-4, Placebo - Angina Pectoris
Phase 3UnknownCardium Therapeutics3002007-05-012013-02-13
Efficiency of a New Therapy to Treat Stenosis of Coronary Vessels in Comparison With Two Already Admitted Therapies
local intracoronary dosis of Paclitaxel - Stable or Unstable Angina Pectoris, Myocardial Ischemia
Phase 3UnknownUniversity Hospital Tuebingen2042005-08-012007-05-16

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Angina, Stable (11)  ·  Angina, Unstable (9)  ·  Coronary Artery Disease (6)  ·  Myocardial Ischemia (6)  ·  Acute Coronary Syndrome (5)  ·  Non-ST Elevated Myocardial Infarction (4)  ·  Atherosclerosis (1)  ·  Coronary Disease (1)  ·  Coronary Stenosis (1)  ·  Diabetes Mellitus (1)  ·  Microvascular Angina (1)  ·  Myocardial Infarction (1)  ·  ST Elevation Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (24)  ·  Heart Diseases (24)  ·  Vascular Diseases (24)  ·  Chest Pain (23)  ·  Neurologic Manifestations (23)  ·  Pain (23)  ·  Pathological Conditions, Signs and Symptoms (23)  ·  Signs and Symptoms (23)  ·  Myocardial Ischemia (18)  ·  Arterial Occlusive Diseases (6)  ·  Arteriosclerosis (6)  ·  Coronary Disease (6)  ·  Infarction (5)  ·  Ischemia (5)

Interventions

Ticagrelor (2)  ·  Acetylcysteine (1)  ·  Adenosine (1)  ·  Allopurinol (1)  ·  Antihypertensive Agents (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Clopidogrel (1)  ·  Exercise (1)  ·  Genotyping Techniques (1)  ·  Immunophenotyping (1)  ·  Trimetazidine (1)  ·  Vitamin E (1)  ·  isosorbide-5-mononitrate (1)  ·  succinobucol (1)

Sponsors

Cardium Therapeutics (2)  ·  Collegium Medicum w Bydgoszczy (2)  ·  Angionetics Inc. (1)  ·  AtheroGenics (1)  ·  Biosensors Europe SA (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Eighth Affiliated Hospital, Sun Yat-sen University (1)  ·  Gennaro Sardella (1)  ·  Isfahan University of Medical Sciences (1)  ·  J.M. ten Berg (1)  ·  Laboratórios Baldacci S.A (1)  ·  Medical University of Warsaw (1)  ·  Ministry of Health, Brazil (1)  ·  Qilu Hospital of Shandong University (1)  ·  Rajaie Cardiovascular Medical and Research Center (1)

Countries

Brazil (3)  ·  Italy (3)  ·  Poland (3)  ·  United States (3)  ·  Canada (2)  ·  Germany (2)  ·  Iran (2)  ·  China (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  South Africa (1)  ·  United Kingdom (1)

Top investigators

Alfredo Zuppiroli, MD (1)  ·  Christian Herdeg, PD (1)  ·  David Antoniucci, MD (1)  ·  Eliano Navarese, MD, PhD (1)  ·  Eric Klug, MD (1)  ·  Gian Franco Gensini, MD (1)  ·  Gianni Maria Santoro, MD (1)  ·  Jacek Kubica, MD, PhD (1)  ·  Jan K Madsen, Consultant (1)  ·  Jean-Claude Tardif, MD (1)  ·  Jens T Lund, Consultant (1)  ·  John Mayo, MD (1)

Results publications

PMID 17825712, PMID 18502300, PMID 19270315, PMID 20031731, PMID 26365936, PMID 26796390, PMID 30994825, PMID 32862716, PMID 34096012

NIH funding

2005 (1), 2014 (1), 2018 (1)